The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis
Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities. Roots Analysis has announced the addition of “ Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030 ” report to its list of offerings. The report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations. The study includes in-depth analyses, highlighting the capabilities of various service / technology providers engaged in this market. Amongst other elements, the report includes: § A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services § An insightful geographical benchmarking of the capabilities of companies...